Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 20-sep-2026 · last seen 20-sep-2026

Selenoproteins in Muscle Aging and Sarcopenia

Current understanding

Selenium status, delivered biologically as selenoproteins (GPX4, SELENOP, SELENOW, SELENOT, SELENON), is proposed as an upstream nutrient input into aging muscle homeostasis — limiting lipid peroxidation and ferroptosis (GPX4), resolving inflammation (SELENOP/W), and supporting protein and calcium handling and regeneration (SELENOT/N). A 2026 systematic review consolidates epidemiological, clinical, and animal evidence for a dose-responsive association between selenium deficiency and sarcopenia risk [human-observational + animal-model], but no dedicated RCT has yet tested selenium repletion for a sarcopenia endpoint, so the causal chain remains inferred rather than established in humans.

Evidence log

Open questions

Related

Contributing findings

pubmed review
Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.
18-sep-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18